Editorial: Targeting Neuregulin1 and HER Receptor Tyrosine Kinases for Therapy of Breast Cancer and Heart Failure

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|30|4854-4855

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.30, 2014-09, pp. : 4854-4855

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuregulin1 as Novel Therapy for Heart Failure

By  

Current Pharmaceutical Design, Vol. 17, Iss. 18, 2011-06 ,pp. : 1808-1817

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of receptor tyrosine kinases in lung cancer

By Choong Nicholas W   Ma Patrick C   Salgia Ravi  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 533-559

Informa Healthcare

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

By  

Current Drug Targets, Vol. 17, Iss. 14, 2016-11 ,pp. : 1687-1703

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting tyrosine-kinases in ovarian cancer

By Morotti Matteo   Becker Christian M   Menada Mario Valenzano   Ferrero Simone  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1265-1279

Informa Healthcare

Access to resources Recommend Favorite